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ABSTRACT
Background Data on myopia prevalence and 
progression in European children are sparse. The aim of 
this work was to evaluate the progression of myopia in 
children and teenagers in a large prospective study.
Methods A prospective study involving a nationwide 
cohort. Myopia was defined as a spherical equivalent 
(SE) of ≤ –0.50 diopters (D). Data on refractive error, 
gender and age were collected in 696 optical centres 
in France between 2013 and 2019, including 136 333 
children (4–17 years old) in the analysis.
Progression of myopia was assessed between the first 
visit and the last visit over up to 6.5 years.
Results Mean age was 11.3±3.8 years (55.0% of 
female). The proportion of children progressing more 
than –0.50 D per year was higher in age groups 7–9 
years and 10–12 years and in children with SE ≤ –4.00 
D at first visit, representing 33.1%, 29.4% and 30.0% 
of these groups, respectively. In multivariate analysis, 
progression during the first 11–24 months was higher in 
the 7–9 and 10–12 age groups (–0.43 D and –0.42 D, 
respectively), for higher SE at baseline (at least –0.33 D 
for SE ≤ –1 D) and for girls (–0.35 D).
Conclusion This is the first French epidemiological 
study to investigate myopia progression in a large- scale 
cohort of children. Sex, age groups and myopia severity 
are associated with differing rates of progression.
INTRODUCTION
A ‘myopia boom’ has been observed in many 
countries, not only in East Asia, but also world-
wide, making myopia a major public health issue.1 
Myopia is defined by a refractive error of −0.50 
diopter (D) or less, and high myopia by refractive 
errors of −5 D or less, and in 2020 they affect 2.6 
billion and 300 million people, respectively, world-
wide (https://www. who. int/ blindness/ causes/ Myop-
iaReportforWeb. pdf). Accelerated evolution of 
lifestyles over recent decades, with more time dedi-
cated to close- range work and mid- distance activi-
ties, combined with marked reduction of outdoor 
activities and more extensive educational coverage, 
likely explain this epidemic to a far greater extent 
than genetic modifications, which usually require 
much more time.2–7
Myopia frequently appears in childhood, with a 
peak incidence occurring between 8 and 10 years 
of age.8 9 There is major disparity in the prevalence 
of myopia in children according to ethnic origin.10 
The progression of myopia has been analysed in 
various studies,8 11–13 and a younger age of myopia 
onset or longer duration of myopia progression is 
strong predictors of high myopia.8 14 15
Epidemiologic data on European myopic chil-
dren are scarce, particularly with respect to myopia 
progression, with most studies focusing on refrac-
tive error in adults. The aim of this study was to 
prospectively study myopia progression among 
children and adolescents in France.
MATERIALS AND METHODS
Dataset description and selection
The original dataset consisted of anonymised elec-
tronic data files collected from 696 French opti-
cians’ stores located in all French metropolitan 
departments between 2013 and 2019. Information 
came from the optical prescriptions provided by 
ophthalmologists. Relevant variables were year of 
birth, sex, prescription date, purchase date, type of 
prescription (glasses, contact lenses), type of vision 
correction (near vision, distance vision, progressive 
glasses, others), sphere and cylinder characteristics 
for both eyes. The spherical equivalent (SE) of the 
right eye only was used to quantify myopia. Myopia 
was defined by an SE ≤ –0.50 D.16
Individuals with at least two prescriptions for 
myopia correction separated by at least 6 months 
were eligible, the first prescription for myopia 
correction in opticians’ stores participating in the 
study being considered as the baseline. One esti-
mate of progression rate was calculated per indi-
vidual, using the last prescription. Age of myopia 
incidence was not known, as baseline refractive 
error varied considerably.
Inclusion criteria were myopia age between 4 and 
17 years at the date of first prescription. Children 
aged 0–3 years were excluded because of their rela-
tively small number and because myopia aetiology 
is considered different for preschoolers.17 Prepro-
cessing and further exclusion steps are summarised 
in figure 1. The most frequent reasons for exclusion 
were age and refractive error.
Myopia progression was defined as the differ-
ence in SE between baseline and subsequent 
prescriptions. Negative values represent myopia 
progression. Time intervals between visits were 
categorised into 6- month intervals. In cases of 
multiple prescriptions within an interval, the visit 
with the most myopic prescription was selected, 
usually the last one. Progressors were defined 
as individuals with a mean rate of progression 
of myopia exceeding –0.50 D/year in the period 
between baseline and a second prescription 
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between 11 and 24 months after baseline. Individuals without 
prescription in this period were excluded from the corre-
sponding analyses.
When comparing the progression of progressors and non- 
progressors, the second prescription was used as the new baseline.
High myopia was defined as SE ≤ –6D. For survival analysis, only 
individuals who did not have high myopia were selected. The inci-
dence date of high myopia was set as the earliest prescription for 
high myopia. When high myopia did not occur, the latest prescrip-
tion date was used (censored observation). To avoid bias due to low 
number of at- risk individuals, prescriptions that occurred more than 
5.5 years after baseline were treated as censored at 5.5 years.
Modeling
We modelled progression with an analysis of variance (ANOVA). 
Covariates included age, SE at baseline and gender, and the 
main variable was progression between 11 and 24 months after 
baseline.
The p values for proportions of progressors were computed 
using logistic regression to model ‘progressor status’ (positive 
if the progression rate is < –0.50 D/year). Covariates were age 
group, SE at baseline and gender.
Survival analysis was performed with a multivariate Cox 
model including the following covariates age, SE at baseline and 
gender.
Patient and public involvement statement




The dataset included 136 333 myopic children and teenagers 
(mean age: 11.3±3.8; 55.0% were female, 130 678 had SE > 
–6D). Median follow- up was 2.7 years. Follow- up duration was 
≥2 years, ≥3 years, ≥4 years and ≥5 years for 90 706 (66.5%), 
61 062 (44.8%), 36 989 (27.1%) and 17 995 (13.2%) partic-
ipants, respectively. Progressor status could be determined for 
88 604 of them (second prescription 11 to 24 months after base-
line) and 50 516 of the latter had a visit following the second 
prescription to estimate later progression. Demographic charac-
teristics and refractive data are detailed in table 1.
Progression of myopia
Progression among age groups was significantly different 
(p<0.0001), with a higher proportion of progressors among 
children aged 7–9 years (33.1 %) and 10–12 years (29.4%) 
compared with other groups (at most 22.1 %). Moreover, 
progression differed significantly in relation to SE (p<0.0001), 
with a higher proportion of progressors among individuals with 
SE ≤ –4.00 D (30.0%) than for others (at most 27.5 %). Finally, 
progression differed significantly between sexes, (p<0.0001) 
with a higher proportion of progression among girls (25.6%) 
than among boys (24.1 %). These numbers are detailed in table 2.
Figure 1 Flow diagram describing data selection. SE, spherical 
equivalent.










All 136 333 11.3±3.8 55.0 −2.10±1.80
  4–6 19 179 5.0±0.8 51.9 −1.90±1.67
  7–9 25 830 8.1±0.8 52.5 −1.78±1.57
  10–12 33 319 11.1±0.8 55.3 −2.03±1.72
  13–15 36 861 14.0±0.8 56.5 −2.29±1.90
  16–17 21 144 16.5±0.5 57.6 −2.48±1.99
With progression status 88 604 11.0±3.8 54.8 −2.12±1.80
With progression status 
and follow- up
50 516 10.4±3.6 53.4 −2.20±1.84
Progressors 13 795 10.2±3.2 55.3 −2.37±1.92
Non- progressors 36 721 10.7±3.7 52.7 −2.14±1.81
Mild or moderate myopia 130 678 11.2±3.8 55.0 −1.85±1.27
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Progression of myopia as a function of age at first myopia 
correction
The rate of myopia progression was essentially linear with time 
within age groups, the most rapid progression being observed 
for children aged 7–9 and 10–12 years at baseline (–0.43 D and 
–0.42 D) (figure 2A and table 3). Progression rate was lower for 
younger and older age groups, and the association between age 
and progression rate was non- linear.
Progression as a function of SE on first myopia correction
Children with SE inferior to –1 D myopia at baseline had faster 
progression (at least –0.33 D in multivariate analysis) than those 
with milder myopia (–0.23 D) (figure 2B and table 3). Rates for 
the other four categories of myopia were very similar (between 
–0.38 and –0.40 D).
Regardless of baseline myopia, progression rate was highest 
for children aged 7–9 years. In particular, individuals with SE ≤ 
–4 D at 9 years had a mean progression of –1.6 D 4–5 years later. 
While the rate of progression was higher for more severe degrees 
of myopia, the pattern of progression followed a U shape similar 
between different myopia subgroups (figure 3).
Myopia progression according to gender
Average progression of myopia was higher among girls (–0.35 D) 
than among boys (–0.32 D) (table 3). After a follow- up of 6–6.5 
years, the mean myopia progression was of –1.42 D for girls and 
of –1.24 D for boys.
Later myopia progression according to initial progression rate
Progressors as defined during the first 11–24 months showed 
faster rates of progression than non- progressors in the follow- up 
period with change equal to –1.69 D (–1.56; –1.81) vs –0.87 D 
(–0.79; –0.95) 5–5.5 years after baseline. This was observed in 
all age groups (figure 4).
Time to develop high myopia
Univariate analysis showed that children with SE ≤ –4.00 D and 
> –6.00 D at baseline had a 58% risk of developing high myopia 
at 5.5 years of follow- up (figure 5). Multivariate analysis showed 
that younger individuals aged 4–12 years, girls and individuals 
Table 2 Proportion (%) of progressors by age at baseline, spherical 
equivalent (SE) at baseline and sex
% progressors 
(N=88 604)










(−1; −0.5) 19.3 36.2
(−2; −1) 25.6 34.6
(−3; −2) 27.3 35.0
(−4; −3) 27.5 34.1
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Figure 2 (A) Average progression of myopia (in diopters) as a function of time (in years) stratified by baseline age groups. Bars display 95% CIs. (B) 
Average progression of myopia (in diopters) as a function of time (in years) stratified by baseline spherical equivalent (SE). Bars display 95% CIs.
Table 3 Average myopia progression (in diopters) between 11 and 
24 months according to age, spherical equivalent at baseline and 
gender: univariate and multivariate analysis. Type 3 test p values for 
the multivariate model: age (p<0.0001), spherical equivalent (SE) 




4–6 –0.15 (–0.17; –0.14) –0.18 (–0.19; –0.16)
7–9 –0.40 (–0.41; –0.39) –0.43 (–0.44; –0.42)
10–12 –0.41 (–0.42; –0.40) –0.42 (–0.43; –0.41)
13–15 –0.35 (–0.36; –0.34) –0.36 (–0.37; –0.35)
16–17 –0.29 (–0.30; –0.27) –0.29 (–0.30; –0.28)
SE
(−1; −0.5) –0.25 (–0.26; –0.24) –0.23 (–0.24; –0.22)
(−2; −1) –0.35 (–0.36; –0.34) –0.33 (–0.34; –0.32)
(−3; −2) –0.38 (–0.39; –0.37) –0.36 (–0.37; –0.35)
(−4; −3) –0.38 (–0.40; –0.37) –0.37 (–0.38; –0.36)
≤ −4 –0.40 (–0.41; –0.39) –0.38 (–0.39; –0.37)
Gender
F –0.35 (–0.35; –0.34) –0.35 (–0.35; –0.34)
M –0.32 (–0.33; –0.32) –0.32 (–0.33; –0.31)
 on M








ol: first published as 10.1136/bjophthalm





4 Tricard D, et al. Br J Ophthalmol 2021;0:1–6. doi:10.1136/bjophthalmol-2020-318256
Clinical science
with higher myopia at baseline were more likely to develop high 
myopia (table 4).
DISCUSSION
The objective of our study was to describe the progression of 
myopia in France using a cohort of individuals aged 4–17 years 
at baseline and followed for up to 6.5 years from 2013 to 2019.
This study showed that factors associated with faster myopia 
progression were gender, with girls being more prone to progres-
sion than boys, higher myopia at baseline, and age between 7 
and 12 years. The large sample size results in a number of signif-
icant differences that are clinically unremarkable. For example, 
the faster progression in females amounts to only 0.18 D over 
6 years. The differences among myopia levels less than –1 D are 
similarly small and not clinically meaningful.
In the current study, we observed a small difference of 0.03 
D or a 9% difference in terms of myopia progression between 
girls and boys. The literature shows that myopic girls progress 
slightly faster than myopic boys. Hyman et al show a difference 
of 0.16 D over 3 years (p<0.05), but there was no difference 
in axial elongation.18 Similarly, Donovan et al considered the 
effect of gender in their meta- analysis on the rates of myopia 
progression. For an average baseline age of 8.8 years, estimated 
annual progression was significantly faster (p<0.01) for females 
(–0.80 D) than for males (–0.71 D).12 This difference has also 
been observed in Indian and Chinese studies19 20 along with 
other longitudinal studies of North American children.21
Despite these convergent results, it is difficult to explain this 
difference. Slightly more nearby work activities or less outdoor 
time among girls could be supposed, but this still remains 
speculative.
Age is the most important factor determining the mean 
progression rate and the proportion of fast progressors, but age 
is not a monotonic factor, with 7–9 year old myopes progressing 
faster and both younger and older children progressing more 
slowly. The slower progression in younger children, with very 
young onset of myopia could reflect a different aetiology. They 
have not been studied as frequently as school- age myopes and 
future research may cast light on this hypothesis.
Few prospective studies have shown the relationship between 
age at myopia onset and myopia severity.8 15 22 Most of them 
have focused on a particular age range, from 7 to 9 years8 22 
or from 9 to 12.15 In the current study, given the large sample 
size, we were able to evaluate the progression of myopia in 
different age groups, from 4 to 17 years old, and showed that 
myopia progressed more rapidly in children aged 7–9 years old 
Figure 3 Average progression of myopia at 4–5 years after baseline; 
as a function of baseline age stratified by baseline spherical equivalent 
























































































































Figure 4 Comparison of average progression of myopia (in diopters) as a function of time (in years) between progressors and non- progressors, 
stratified by age at baseline. (A) between 4 and 12 years, (B) between 13 and 17 years. ‘Second prescription’ refers to the prescription used to 
characterise the progression status with respect to baseline (first prescription). Bars display 95% CIs.
Figure 5 Kaplan- Meier failure curves for the event ‘develops high 
myopia’ stratified by spherical equivalent at baseline.
 on M
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and 10–12 years old, with mean myopia progression of –0.40 D 
and –0.41 D over 11–24 months, respectively. These progression 
rates are smaller than those reported in different clinical trials 
conducted in Taiwan, Singapore, China and Hong Kong23–28 
with reported values varying from –0.63 D/year to –2.00 D/
year. Ethnicity is clearly an important factor in rate of progres-
sion with children of East Asian descent progressing faster than 
those of European ancestry.12 This difference could be partially 
explained by different exposure to environmental and genetic 
risk factors and by the fact that children included in interven-
tional clinical trials may be more prone to faster progression 
than those in an observational study. However, the progres-
sion reported in our study is relatively close to the mean rate of 
progression reported in the control arm of children aged 6–15 
years of the Houston Myopia Control Study (–0.34 D/year),29 
and of myopic children aged 5–15 years in the North India 
Myopia Study (–0.27 D/year).30 The recently completed Bifocal 
Lenses In Nearsighted Kids Study reported a 3- year progression 
of –1.05 D in the control group wearing single vision soft lenses 
(–0.35 D/year).31 An earlier 3- year clinical trial reported a 3- year 
progression of –1.10 D in the control group wearing spectacles 
(–0.37 D/year).32 The majority of children in both studies were 
of European descent and the mean age at baseline was around 
10 years.
We also analysed the percentage of children progressing by 
at least 0.50 D/year over the first 11–24 months, since this is a 
proposed criterion for the implementation of preventive strat-
egies aimed at reducing myopia progression.33 In this context, 
higher proportions of progressors were observed within the 
7–9 and 10–12 years old age groups, accounting for 33.1% and 
29.4%, respectively, compared with 24.9% of the whole cohort 
(table 2).
Furthermore, the initial progressor profile defined within 
the 11–24- month period following the baseline correction was 
predictive of higher progression of myopia during the 5.5 years 
of follow- up for almost all age groups, except for 16–17 years 
(figure 4). This could be explained by the fact that the mean age 
at myopia stabilisation is usually close to this age range.11 We 
also observed that every diopter at baseline matters appreciably 
in terms of risk of developing high myopia during the follow- up. 
Indeed, between myopia ranges –3 to –4 and –4 to –6 D (–6 D 
being excluded), the risk of developing high myopia increased 
from 16% to 58% (figure 5). These observations call for precise 
screening and follow- up of myopic children during an era of 
preventive approaches regarding myopia progression.
The increased prevalence of myopia in industrialised countries 
could be largely due to lifestyle, notably a reduction in outdoor 
activities combined with an increase of close- range work activities 
and more intensive and extensive educational coverage.2–7 34–36 
Estimates state that in children a reduction in the risk of myopia 
is obtained for each hour a week spent outdoors.34 Furthermore, 
early exposure to daylight could have a beneficial impact on the 
development of myopia. Indeed, a Chinese study showed that 
children born in winter are more prone to become myopic than 
children born in other seasons.37 More accurate estimation of 
myopia progression and its risk factors may be accompanied 
by more personalised preventive strategies combining a modi-
fication of life style2–7 35 38 and pharmacological19–27 or optical 
approaches31 39 in view of preventing myopia progression. In 
fact, it is likely that reduction of myopia progression during 
childhood could have an impact on myopia severity in adult-
hood and may thereby influence the incidence of myopia- related 
complications, that is, glaucoma, cataract, retinal detachment, 
myopic maculopathy and myopic neovascularisation.40
Strengths and limitations of this study
This is the first prospective study on myopia including a large 
sample of over 130 000 children and teenagers. The strength of 
this study is its design, which provided original data on myopia 
progression according to age, gender and degree of myopia in 
a very large, young population over a 6.5- year period. We also 
acknowledge several weaknesses in this study. First, information 
on cycloplegia prior to refractive error measurement was not 
included, even though, according to national recommendations, 
cycloplegia is usually used in children. This may have resulted 
in some of the children in the lowest myopia category being 
misclassified, perhaps accounting for the slower progression 
rate among these subjects. In longitudinal clinical studies and 
trials, autorefraction is preferred. Likewise, axial length was not 
measured in this study.
Second, children with more rapid and longer myopia progres-
sion could be over- represented, given that they would require 
more frequent changes of optical correction than those with 
more stable vision. This may explain a paradox in the data: while 
it is clear that older children progress more slowly (figure 2A), 
the different age groups do not appear to slow over time. This 
may be due to more stable children having shorter follow- up 
and only those who continue to progress attending examina-
tion later in the study. Furthermore, the fact that progression 
rates remain linear within each of the age groups can reflect 
the fact that prescription of optical correction prevents accel-
erated progression during the 7–9- year period. Progression in 
children wearing a myopic correction may be faster compared 
with those uncorrected, although deliberate undercorrection 
may accelerate progression.41 Thus, the inclusion of only chil-
dren receiving prescriptions in the current study may have influ-
enced progression rates. Furthermore, because it is likely that a 
new prescription was given in case of modification of refractive 
error of ±0.50 D and no lesser, smaller refractive changes were 
possibly not reported, despite smaller progression.
CONCLUSION
This is the first French prospective study on myopia in chil-
dren with a large sample size, providing estimations of myopia 
Table 4 Hazard ratios and 95% CI for the event ‘develops high 
myopia’ from a multivariate Cox model. Type 3 test p values are 
displayed
Multivariate HR (95% CI)
Age P value<0.0001
4–6 2.07 (1.85 to 2.31)
7–9 2.59 (2.34 to 2.86)
10–12 2.06 (1.88 to 2.27)
13–15 1.33 (1.21 to 1.46)
16–17 Reference
Spherical equivalent p value<0.0001
(−1; −0.5) Reference
(−2; −1) 4.78 (3.16 to 7.22)
(−3; −2) 17.81 (11.96 to 26.52)
(−4; −3) 56.73 (38.34 to 83.96)
≤ −4 398.35 (270.80 to 585.99)
Gender p value<0.0001
M Reference
F 1.18 (1.12 to 1.25)
 on M
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progression according to age, gender and initial degree of 
myopia at first correction.
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